Home  /  Resource Library  /  Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study

Mosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study

Study investigated mosunetuzumab for treatment of elderly patients with relapsed follicular lymphoma.